December 12, 2006 — Health Canada has approved a pen-like device for administering adalimumab in the treatment of moderate to severe rheumatoid arthritis and psoriatic arthritis; the European ...
JERSEY CITY, N.J. & INCHEON, Korea--(BUSINESS WIRE)--Organon & Co. (NYSE: OGN) & Samsung Bioepis Co., Ltd. today announced that HADLIMA™ (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab) ...
As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
June 27, 2006 — The US Food and Drug Administration (FDA) has approved a pill-swallowing cup to facilitate ingestion of medications and vitamins in patients who have difficulty swallowing; an ...
ABBOTT PARK, Ill., June 26 (UPI) -- Abbott said Monday the Food and Drug Administration approved its Humira Pen, a device for administering the arthritis therapy. The pen, which has a one-touch ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a new autoinjector pen option for Cyltezo, an interchangeable biosimilar to Humira. Cyltezo ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Patients in the US are paying a sticker price upwards of $3,000 per pen for blockbuster arthritis drug ...
On May 22, 2023, Boehringer Ingelheim announced that the FDA has approved the Cyltezo Pen, a new autoinjector option for Cyltezo (adalimumab-adbm). According to a previous announcement from Boehringer ...
ABBOTT PARK, Ill., June 26 (UPI) -- Abbott said Monday the Food and Drug Administration approved its Humira Pen, a device for administering the arthritis therapy. The pen, which has a one-touch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results